APA (7th ed.) Citation

MF, N., B, T., 3rd, P. W., & WR, S. (2017). Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 31(4), 317. https://doi.org/10.1007/s40259-017-0234-5

Chicago Style (17th ed.) Citation

MF, Naso, Tomkowicz B, Perry WL 3rd, and Strohl WR. "Adeno-Associated Virus (AAV) as a Vector for Gene Therapy." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 31, no. 4 (2017): 317. https://doi.org/10.1007/s40259-017-0234-5.

MLA (9th ed.) Citation

MF, Naso, et al. "Adeno-Associated Virus (AAV) as a Vector for Gene Therapy." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 31, no. 4, 2017, p. 317, https://doi.org/10.1007/s40259-017-0234-5.